Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®

Enrolling by invitationOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 3, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Adult Growth Hormone Deficiency
Interventions
DRUG

Somapacitan

Sogroya® therapy in participants with AGHD (only severe case) under normal clinical practice conditions

Trial Locations (47)

661-0002

Ikeda Hospital, Diabetes Medicine, Amagasaki-shi, Hyogo

409-3821

University of Yamanashi Hospital, Chuo-shi, Yamanashi-ken

818 8502

Fukuoka University Chikushi Hospital_Endocrinology and Diabetes Mellitus, Fukuoka

830-0011

Kurume University Hospital, Fukuoka

814-0133

Fukuoka University Hospital, Fukuoka-shi, Fukuoka-ken

812-8582

Kyushu University Hospital, Fukuoka-shi, Fukuoka

501-1194

Gifu University Hospital, Gifu

037-0074

Tsugaru General Hospital, Goshogawara-shi, Aomori-ken

371-8511

Gunma University Hospital, Dept. of Endocrinology and Diabetes, Gunma

431-3192

Hamamatsu University Hospital, Hamamatsu-shi, Shizuoka

036-8203

Hirosaki University Hospital, Hirosaki-shi, Aomori-ken

675-8555

Hyogo Prefectural Kakogawa Medical Center, Hyōgo

395-0804

Takara Clinic, Iida-shi, Nagano-ken

691-8501

Shimane Univ. HP, Dept of Endocrinology&Metabolism, Izumo, Shimane

943-0172

Joetsu General Hospital, Joetsu-shi, Niigata-ken

892-0853

Kagoshima Medical Center, Kagoshima-shi, Kagoshima-ken

890-8520

Kagoshima University Hospital_Neurosurgery, Kagoshima-shi, Kagoshima

245-8575

Yokohama Medical Center, Kanagawa

252-0375

Kitasato University Hospital, Kanagawa

634-8522

Nara Medical University Hospital_Kashihara-shi, Nara, Kashihara-shi, Nara

211-8533

Nippon Medical School Musashikosugi Hospital_Neurological Surgery, Kawasaki-shi, Kanagawa

650-0017

Kobe University Hospital, Kobe-shi, Hyogo

862-0970

Konan Hospital, Kumamoto

860-0811

Kumamoto University Hospital, Diabetes, Metabo and Endo, Kumamoto-shi, Kumamoto

606-8507

Kyoto University Hospital, Kyoto-shi, Kyoto

105-8470

Toranomon Hospital, Endocrinology and Metabolism, Minato-ku, Tokyo

889-1601

University of Miyazaki Hospital, Miyazaki-shi, Miyazaki-ken

480-1195

Aichi Medical University Hospital, Nagakute-shi, Aichi

633-0064

Okamoto Internal Medicine and Pediatrics Clinic, Nara

663-8024

Kurebayashi Diabetes Clinic, Nishinomiya-shi, Hyogo-ken

700-8558

Okayama University Hospital_General Medicine, Okayama-shi, Okayama

530-0013

Osaka Endocrine Clinic, Osaka

540-0003

Kibounomori Clinic, Osaka

545-8586

Osaka City University Hospital, Osaka

572-0085

Yasuhara Children's Clinic, Osaka

594-1101

Osaka Women's and Children's Hospital, Osaka

060-8648

NTT East Japan Sapporo HP, Diabetes Mellitus & Int med Endo, Sapporo, Hokkaido

981-3205

JCHO Sendai Hospital, Sendai-shi, Miyagi-ken

525-8585

Omi Medical Center, Shiga

431-3113

Hamamatsu-kita-Hospital, Shizuoka

432-8580

Hamamatsu Medical Center, Shizuoka

420-0881

Shizuoka General Hospital, Shizuoka-shi, Shizuoka-ken

329-4407

Tochigi Medical Center Shimotsuga, Tochigi-shi, Tochigi-ken

112-0001

Hosaka Kodomo Clinic, Tokyo

791-0295

Ehime University Hospital, Toon-shi, Ehime

683-8504

Tottori University Hospital_Endocrinology and Metabolism, Tottori

990-9585

Yamagata University Hospital, Internal Medicine 3, Yamagata-shi, Yamagata

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY